STERIS (STE) Competitors $221.16 -2.85 (-1.27%) Closing price 03:59 PM EasternExtended Trading$221.16 0.00 (0.00%) As of 04:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock STE vs. BDX, EW, RMD, IDXX, DXCM, PODD, BAX, HOLX, GMED, and MASIShould you be buying STERIS stock or one of its competitors? The main competitors of STERIS include Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), ResMed (RMD), IDEXX Laboratories (IDXX), DexCom (DXCM), Insulet (PODD), Baxter International (BAX), Hologic (HOLX), Globus Medical (GMED), and Masimo (MASI). These companies are all part of the "health care equipment" industry. STERIS vs. Becton, Dickinson and Company Edwards Lifesciences ResMed IDEXX Laboratories DexCom Insulet Baxter International Hologic Globus Medical Masimo STERIS (NYSE:STE) and Becton, Dickinson and Company (NYSE:BDX) are both large-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, media sentiment, community ranking, dividends, valuation and earnings. Is STE or BDX a better dividend stock? STERIS pays an annual dividend of $2.28 per share and has a dividend yield of 1.0%. Becton, Dickinson and Company pays an annual dividend of $4.16 per share and has a dividend yield of 2.1%. STERIS pays out 48.4% of its earnings in the form of a dividend. Becton, Dickinson and Company pays out 69.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. STERIS has increased its dividend for 20 consecutive years and Becton, Dickinson and Company has increased its dividend for 53 consecutive years. Becton, Dickinson and Company is clearly the better dividend stock, given its higher yield and longer track record of dividend growth. Which has more volatility & risk, STE or BDX? STERIS has a beta of 0.87, meaning that its share price is 13% less volatile than the S&P 500. Comparatively, Becton, Dickinson and Company has a beta of 0.35, meaning that its share price is 65% less volatile than the S&P 500. Is STE or BDX more profitable? STERIS has a net margin of 8.66% compared to Becton, Dickinson and Company's net margin of 8.47%. Becton, Dickinson and Company's return on equity of 15.74% beat STERIS's return on equity.Company Net Margins Return on Equity Return on Assets STERIS8.66% 13.91% 8.64% Becton, Dickinson and Company 8.47%15.74%7.29% Which has better earnings and valuation, STE or BDX? Becton, Dickinson and Company has higher revenue and earnings than STERIS. Becton, Dickinson and Company is trading at a lower price-to-earnings ratio than STERIS, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSTERIS$5.40B4.03$378.24M$4.7146.96Becton, Dickinson and Company$20.64B2.81$1.71B$6.0233.56 Does the media refer more to STE or BDX? In the previous week, Becton, Dickinson and Company had 18 more articles in the media than STERIS. MarketBeat recorded 39 mentions for Becton, Dickinson and Company and 21 mentions for STERIS. STERIS's average media sentiment score of 1.42 beat Becton, Dickinson and Company's score of 1.01 indicating that STERIS is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment STERIS 16 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Becton, Dickinson and Company 26 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive Does the MarketBeat Community prefer STE or BDX? Becton, Dickinson and Company received 264 more outperform votes than STERIS when rated by MarketBeat users. Likewise, 62.42% of users gave Becton, Dickinson and Company an outperform vote while only 59.16% of users gave STERIS an outperform vote. CompanyUnderperformOutperformSTERISOutperform Votes33959.16% Underperform Votes23440.84% Becton, Dickinson and CompanyOutperform Votes60362.42% Underperform Votes36337.58% Do analysts prefer STE or BDX? STERIS presently has a consensus target price of $258.75, suggesting a potential upside of 16.99%. Becton, Dickinson and Company has a consensus target price of $275.71, suggesting a potential upside of 36.48%. Given Becton, Dickinson and Company's stronger consensus rating and higher probable upside, analysts plainly believe Becton, Dickinson and Company is more favorable than STERIS.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score STERIS 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80Becton, Dickinson and Company 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders and institutionals have more ownership in STE or BDX? 94.7% of STERIS shares are held by institutional investors. Comparatively, 87.0% of Becton, Dickinson and Company shares are held by institutional investors. 1.1% of STERIS shares are held by company insiders. Comparatively, 0.4% of Becton, Dickinson and Company shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. SummaryBecton, Dickinson and Company beats STERIS on 12 of the 21 factors compared between the two stocks. Remove Ads Get STERIS News Delivered to You Automatically Sign up to receive the latest news and ratings for STE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart STE vs. The Competition Export to ExcelMetricSTERISSurgical appliances & supplies IndustryMedical SectorNYSE ExchangeMarket Cap$21.73B$8.62B$5.33B$18.52BDividend Yield1.05%1.71%5.11%4.24%P/E Ratio46.9618.5321.8131.16Price / Sales4.0372.21379.3725.68Price / Cash15.7319.6738.1517.53Price / Book3.384.866.464.29Net Income$378.24M$284.66M$3.20B$1.02B7 Day Performance6.20%5.71%6.63%6.58%1 Month Performance-2.59%-1.66%-8.50%-6.89%1 Year Performance9.89%-21.45%10.47%1.21% STERIS Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)STESTERIS4.5996 of 5 stars$221.17-1.3%$258.75+17.0%+9.9%$21.73B$5.40B46.9616,000Positive NewsBDXBecton, Dickinson and Company4.833 of 5 stars$204.88-1.2%$275.71+34.6%-12.6%$58.83B$20.64B34.0377,000Short Interest ↑Analyst RevisionPositive NewsHigh Trading VolumeEWEdwards Lifesciences4.5147 of 5 stars$69.00-0.5%$79.95+15.9%-22.6%$40.56B$5.44B9.9017,300Insider TradeNews CoveragePositive NewsRMDResMed4.4085 of 5 stars$213.06+3.8%$249.73+17.2%+15.4%$31.29B$4.93B25.158,160Analyst RevisionPositive NewsHigh Trading VolumeIDXXIDEXX Laboratories4.8013 of 5 stars$378.99-3.7%$533.75+40.8%-18.7%$30.71B$3.90B35.5210,800Analyst DowngradePositive NewsHigh Trading VolumeDXCMDexCom4.907 of 5 stars$61.63+3.0%$99.82+62.0%-50.5%$24.17B$4.03B43.107,600Positive NewsGap DownHigh Trading VolumePODDInsulet4.5741 of 5 stars$256.23+4.5%$292.06+14.0%+45.8%$17.99B$2.07B44.252,600Short Interest ↓Positive NewsBAXBaxter International4.556 of 5 stars$28.61-0.6%$38.56+34.8%-29.8%$14.67B$10.64B-22.3560,000HOLXHologic4.8247 of 5 stars$61.27+0.7%$84.62+38.1%-23.9%$13.75B$4.04B19.336,940Positive NewsHigh Trading VolumeGMEDGlobus Medical4.7611 of 5 stars$70.74+2.8%$97.09+37.2%+41.3%$9.73B$2.52B94.322,600Short Interest ↑News CoveragePositive NewsGap DownMASIMasimo4.3886 of 5 stars$150.36+4.1%$194.80+29.6%+11.4%$8.12B$2.09B103.706,200Positive NewsGap Down Remove Ads Related Companies and Tools Related Companies Becton, Dickinson and Company Alternatives Edwards Lifesciences Alternatives ResMed Alternatives IDEXX Laboratories Alternatives DexCom Alternatives Insulet Alternatives Baxter International Alternatives Hologic Alternatives Globus Medical Alternatives Masimo Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:STE) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding STERIS plc Please log in to your account or sign up in order to add this asset to your watchlist. Share STERIS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.